25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SEQUA (Sequana Medical NV) Stock Analysis
Buy, Hold or Sell?

Let's analyze Sequana Medical NV together

I guess you are interested in Sequana Medical NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Sequana Medical NV’s Financial Insights
  • 📈 Technical Analysis (TA) – Sequana Medical NV’s Price Targets

I'm going to help you getting a better view of Sequana Medical NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sequana Medical NV

I send you an email if I find something interesting about Sequana Medical NV.

1. Quick Overview

1.1. Quick analysis of Sequana Medical NV (30 sec.)










1.2. What can you expect buying and holding a share of Sequana Medical NV? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.78
Expected worth in 1 year
€-2.52
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€-1.74
Return On Investment
-113.6%

For what price can you sell your share?

Current Price per Share
€1.53
Expected price per share
€0.9 - €1.774
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sequana Medical NV (5 min.)




Live pricePrice per Share (EOD)
€1.53
Intrinsic Value Per Share
€-3.58 - €-2.67
Total Value Per Share
€-4.36 - €-3.44

2.2. Growth of Sequana Medical NV (5 min.)




Is Sequana Medical NV growing?

Current yearPrevious yearGrowGrow %
How rich?-$52.4m-$22.9m-$29.4m-56.1%

How much money is Sequana Medical NV making?

Current yearPrevious yearGrowGrow %
Making money-$52.7m-$38.4m-$14.2m-27.1%
Net Profit Margin-42,126.4%-4,572.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Sequana Medical NV (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#293 / 298

Most Revenue
#273 / 298

Most Profit
#286 / 298

Most Efficient
#297 / 298
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sequana Medical NV?

Welcome investor! Sequana Medical NV's management wants to use your money to grow the business. In return you get a share of Sequana Medical NV.

First you should know what it really means to hold a share of Sequana Medical NV. And how you can make/lose money.

Speculation

The Price per Share of Sequana Medical NV is €1.534. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sequana Medical NV.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sequana Medical NV, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.78. Based on the TTM, the Book Value Change Per Share is €-0.44 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sequana Medical NV.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.92-60.1%-0.92-60.1%-0.67-43.8%-0.74-48.4%-0.62-40.6%-0.44-28.7%
Usd Book Value Change Per Share-0.51-33.5%-0.51-33.5%-0.36-23.3%-0.30-19.6%-0.19-12.2%-0.09-6.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.51-33.5%-0.51-33.5%-0.36-23.3%-0.30-19.6%-0.19-12.2%-0.09-6.0%
Usd Price Per Share3.61-3.61-4.72-5.14-7.66-4.57-
Price to Earnings Ratio-3.92--3.92--7.03--7.37--15.15--9.97-
Price-to-Total Gains Ratio-7.03--7.03--13.22--90.49--316.48--260.70-
Price to Book Ratio-3.94--3.94--11.76--58.37-1,052.40-564.88-
Price-to-Total Gains Ratio-7.03--7.03--13.22--90.49--316.48--260.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.8113472
Number of shares552
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.51-0.19
Usd Total Gains Per Share-0.51-0.19
Gains per Quarter (552 shares)-283.85-103.23
Gains per Year (552 shares)-1,135.39-412.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1135-11450-413-423
20-2271-22800-826-836
30-3406-34150-1239-1249
40-4542-45500-1652-1662
50-5677-56850-2065-2075
60-6812-68200-2478-2488
70-7948-79550-2891-2901
80-9083-90900-3303-3314
90-10219-102250-3716-3727
100-11354-113600-4129-4140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%2.08.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%2.08.00.020.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sequana Medical NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.435-0.4350%-0.303-31%-0.254-42%-0.158-64%-0.078-82%
Book Value Per Share---0.776-0.7760%-0.340-56%-0.385-50%-0.233-70%-0.168-78%
Current Ratio--0.1210.1210%0.323-63%0.656-82%1.203-90%1.015-88%
Debt To Asset Ratio--5.4635.4630%2.927+87%3.158+73%2.304+137%2.516+117%
Debt To Equity Ratio----0%-0%-0%25.010-100%13.415-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--124545376.000124545376.0000%201856320.000-38%220118590.333-43%351791470.400-65%352375284.833-65%
Eps---0.781-0.7810%-0.569-27%-0.629-19%-0.527-33%-0.373-52%
Ev To Ebitda Ratio---7.160-7.1600%-6.928-3%-8.509+19%-16.592+132%-18.110+153%
Ev To Sales Ratio--1174.9561174.9560%283.437+315%606.777+94%733.877+60%672.572+75%
Free Cash Flow Per Share---0.359-0.3590%-0.520+45%-0.457+27%-0.418+17%-0.316-12%
Free Cash Flow To Equity Per Share--0.0210.0210%-0.285+1457%-0.035+265%-0.007+133%-0.001+106%
Gross Profit Margin--1.0001.0000%1.055-5%1.043-4%1.068-6%1.138-12%
Intrinsic Value_10Y_max---2.669----------
Intrinsic Value_10Y_min---3.584----------
Intrinsic Value_1Y_max---0.386----------
Intrinsic Value_1Y_min---0.437----------
Intrinsic Value_3Y_max---1.070----------
Intrinsic Value_3Y_min---1.253----------
Intrinsic Value_5Y_max---1.645----------
Intrinsic Value_5Y_min---1.998----------
Market Cap87759526.400-99%175061376.000175061376.0000%228838400.000-24%249052458.667-30%370947046.400-53%221286732.800-21%
Net Profit Margin---421.264-421.2640%-45.724-89%-166.776-60%-116.780-72%-63.547-85%
Operating Margin---169.896-169.8960%-41.411-76%-81.276-52%-64.703-62%-37.250-78%
Operating Ratio--177.472177.4720%42.411+318%83.777+112%66.563+167%38.670+359%
Pb Ratio-1.978+50%-3.945-3.9450%-11.756+198%-58.372+1380%1052.395-100%564.876-101%
Pe Ratio-1.965+50%-3.920-3.9200%-7.027+79%-7.369+88%-15.151+286%-9.966+154%
Price Per Share1.534-99%3.0603.0600%4.000-24%4.353-30%6.484-53%3.868-21%
Price To Free Cash Flow Ratio-4.278+50%-8.533-8.5330%-7.686-10%-9.470+11%-17.170+101%-10.489+23%
Price To Total Gains Ratio-3.523+50%-7.027-7.0270%-13.219+88%-90.490+1188%-316.475+4404%-260.697+3610%
Quick Ratio--0.0720.0720%0.135-47%0.487-85%0.940-92%0.701-90%
Return On Assets---4.491-4.4910%-3.224-28%-2.965-34%-2.369-47%-2.611-42%
Return On Equity----0%-0%-0%-33.8880%-18.5610%
Total Gains Per Share---0.435-0.4350%-0.303-31%-0.254-42%-0.158-64%-0.078-82%
Usd Book Value---52402723.200-52402723.2000%-22984477.459-56%-25976586.874-50%-15745161.277-70%-11343742.442-78%
Usd Book Value Change Per Share---0.514-0.5140%-0.357-31%-0.300-42%-0.187-64%-0.092-82%
Usd Book Value Per Share---0.916-0.9160%-0.402-56%-0.454-50%-0.275-70%-0.198-78%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--147063179.981147063179.9810%238351942.656-38%259916031.466-43%415395368.248-65%416084736.331-65%
Usd Eps---0.922-0.9220%-0.672-27%-0.743-19%-0.622-33%-0.440-52%
Usd Free Cash Flow---24224112.000-24224112.0000%-35157257.280+45%-30877007.242+27%-28229166.916+17%-21367599.775-12%
Usd Free Cash Flow Per Share---0.423-0.4230%-0.615+45%-0.540+27%-0.493+17%-0.373-12%
Usd Free Cash Flow To Equity Per Share--0.0250.0250%-0.337+1457%-0.041+265%-0.008+133%-0.002+106%
Usd Market Cap103626448.773-99%206712472.781206712472.7810%270212382.720-24%294081143.194-30%438014272.389-53%261295374.090-21%
Usd Price Per Share1.811-99%3.6133.6130%4.723-24%5.140-30%7.656-53%4.567-21%
Usd Profit---52727443.200-52727443.2000%-38451068.179-27%-42501186.989-19%-35589770.859-33%-25200546.623-52%
Usd Revenue--125164.800125164.8000%840933.878-85%685202.496-82%726106.982-83%1127916.573-89%
Usd Total Gains Per Share---0.514-0.5140%-0.357-31%-0.300-42%-0.187-64%-0.092-82%
 EOD+2 -6MRQTTM+0 -0YOY+9 -273Y+9 -275Y+11 -2610Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Sequana Medical NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.965
Price to Book Ratio (EOD)Between0-1-1.978
Net Profit Margin (MRQ)Greater than0-421.264
Operating Margin (MRQ)Greater than0-169.896
Quick Ratio (MRQ)Greater than10.072
Current Ratio (MRQ)Greater than10.121
Debt to Asset Ratio (MRQ)Less than15.463
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-4.491
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Sequana Medical NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.835
Ma 20Greater thanMa 501.116
Ma 50Greater thanMa 1001.063
Ma 100Greater thanMa 2001.198
OpenGreater thanClose1.598
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Sequana Medical NV

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.

Fundamental data was last updated by Penke on 2025-06-17 18:59:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sequana Medical NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Net Profit Margin of -42,126.4% means that €-421.26 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sequana Medical NV:

  • The MRQ is -42,126.4%. The company is making a huge loss. -2
  • The TTM is -42,126.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42,126.4%TTM-42,126.4%0.0%
TTM-42,126.4%YOY-4,572.4%-37,554.0%
TTM-42,126.4%5Y-11,678.0%-30,448.4%
5Y-11,678.0%10Y-6,354.7%-5,323.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-42,126.4%-7.2%-42,119.2%
TTM-42,126.4%-10.2%-42,116.2%
YOY-4,572.4%-10.9%-4,561.5%
3Y-16,677.6%-12.8%-16,664.8%
5Y-11,678.0%-10.3%-11,667.7%
10Y-6,354.7%-9.3%-6,345.4%
4.3.1.2. Return on Assets

Shows how efficient Sequana Medical NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • -449.1% Return on Assets means that Sequana Medical NV generated €-4.49 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sequana Medical NV:

  • The MRQ is -449.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -449.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-449.1%TTM-449.1%0.0%
TTM-449.1%YOY-322.4%-126.7%
TTM-449.1%5Y-236.9%-212.1%
5Y-236.9%10Y-261.1%+24.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-449.1%-2.1%-447.0%
TTM-449.1%-2.3%-446.8%
YOY-322.4%-3.3%-319.1%
3Y-296.5%-2.7%-293.8%
5Y-236.9%-2.6%-234.3%
10Y-261.1%-2.4%-258.7%
4.3.1.3. Return on Equity

Shows how efficient Sequana Medical NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • 0.0% Return on Equity means Sequana Medical NV generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sequana Medical NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-3,388.8%+3,388.8%
5Y-3,388.8%10Y-1,856.1%-1,532.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.8%+1.8%
TTM--2.3%+2.3%
YOY--3.1%+3.1%
3Y--3.8%+3.8%
5Y-3,388.8%-4.2%-3,384.6%
10Y-1,856.1%-6.1%-1,850.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sequana Medical NV.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sequana Medical NV is operating .

  • Measures how much profit Sequana Medical NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • An Operating Margin of -16,989.6% means the company generated €-169.90  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sequana Medical NV:

  • The MRQ is -16,989.6%. The company is operating very inefficient. -2
  • The TTM is -16,989.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16,989.6%TTM-16,989.6%0.0%
TTM-16,989.6%YOY-4,141.1%-12,848.6%
TTM-16,989.6%5Y-6,470.3%-10,519.3%
5Y-6,470.3%10Y-3,725.0%-2,745.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,989.6%-12.1%-16,977.5%
TTM-16,989.6%-13.6%-16,976.0%
YOY-4,141.1%-9.9%-4,131.2%
3Y-8,127.6%-11.1%-8,116.5%
5Y-6,470.3%-9.5%-6,460.8%
10Y-3,725.0%-7.3%-3,717.7%
4.3.2.2. Operating Ratio

Measures how efficient Sequana Medical NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 177.47 means that the operating costs are €177.47 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sequana Medical NV:

  • The MRQ is 177.472. The company is inefficient in keeping operating costs low. -1
  • The TTM is 177.472. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ177.472TTM177.4720.000
TTM177.472YOY42.411+135.061
TTM177.4725Y66.563+110.909
5Y66.56310Y38.670+27.893
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ177.4721.391+176.081
TTM177.4721.361+176.111
YOY42.4111.272+41.139
3Y83.7771.335+82.442
5Y66.5631.342+65.221
10Y38.6701.321+37.349
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sequana Medical NV.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sequana Medical NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.12 means the company has €0.12 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sequana Medical NV:

  • The MRQ is 0.121. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.121. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.121TTM0.1210.000
TTM0.121YOY0.323-0.203
TTM0.1215Y1.203-1.083
5Y1.20310Y1.015+0.188
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1212.525-2.404
TTM0.1212.625-2.504
YOY0.3232.651-2.328
3Y0.6562.907-2.251
5Y1.2033.539-2.336
10Y1.0153.320-2.305
4.4.3.2. Quick Ratio

Measures if Sequana Medical NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Quick Ratio of 0.07 means the company can pay off €0.07 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sequana Medical NV:

  • The MRQ is 0.072. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.072. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.072TTM0.0720.000
TTM0.072YOY0.135-0.063
TTM0.0725Y0.940-0.869
5Y0.94010Y0.701+0.239
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0721.107-1.035
TTM0.0721.412-1.340
YOY0.1351.652-1.517
3Y0.4871.816-1.329
5Y0.9402.145-1.205
10Y0.7012.375-1.674
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sequana Medical NV.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sequana Medical NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sequana Medical NV to Medical Devices industry mean.
  • A Debt to Asset Ratio of 5.46 means that Sequana Medical NV assets are financed with 546.3% credit (debt) and the remaining percentage (100% - 546.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sequana Medical NV:

  • The MRQ is 5.463. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.463. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ5.463TTM5.4630.000
TTM5.463YOY2.927+2.536
TTM5.4635Y2.304+3.159
5Y2.30410Y2.516-0.212
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4630.400+5.063
TTM5.4630.410+5.053
YOY2.9270.391+2.536
3Y3.1580.388+2.770
5Y2.3040.414+1.890
10Y2.5160.455+2.061
4.5.4.2. Debt to Equity Ratio

Measures if Sequana Medical NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sequana Medical NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y25.010-25.010
5Y25.01010Y13.415+11.595
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.554-0.554
TTM-0.636-0.636
YOY-0.589-0.589
3Y-0.638-0.638
5Y25.0100.647+24.363
10Y13.4150.754+12.661
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Sequana Medical NV generates.

  • Above 15 is considered overpriced but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A PE ratio of -3.92 means the investor is paying €-3.92 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sequana Medical NV:

  • The EOD is -1.965. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.920. Based on the earnings, the company is expensive. -2
  • The TTM is -3.920. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.965MRQ-3.920+1.955
MRQ-3.920TTM-3.9200.000
TTM-3.920YOY-7.027+3.107
TTM-3.9205Y-15.151+11.230
5Y-15.15110Y-9.966-5.184
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.965-1.165-0.800
MRQ-3.920-1.449-2.471
TTM-3.920-1.183-2.737
YOY-7.027-1.829-5.198
3Y-7.369-1.328-6.041
5Y-15.151-1.482-13.669
10Y-9.966-1.607-8.359
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sequana Medical NV:

  • The EOD is -4.278. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.533. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.533. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.278MRQ-8.533+4.256
MRQ-8.533TTM-8.5330.000
TTM-8.533YOY-7.686-0.848
TTM-8.5335Y-17.170+8.637
5Y-17.17010Y-10.489-6.682
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.278-2.407-1.871
MRQ-8.533-3.182-5.351
TTM-8.533-1.554-6.979
YOY-7.686-3.394-4.292
3Y-9.470-2.971-6.499
5Y-17.170-2.902-14.268
10Y-10.489-3.379-7.110
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sequana Medical NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -3.94 means the investor is paying €-3.94 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sequana Medical NV:

  • The EOD is -1.978. Based on the equity, the company is expensive. -2
  • The MRQ is -3.945. Based on the equity, the company is expensive. -2
  • The TTM is -3.945. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.978MRQ-3.945+1.967
MRQ-3.945TTM-3.9450.000
TTM-3.945YOY-11.756+7.812
TTM-3.9455Y1,052.395-1,056.340
5Y1,052.39510Y564.876+487.520
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.9781.916-3.894
MRQ-3.9451.993-5.938
TTM-3.9452.254-6.199
YOY-11.7562.634-14.390
3Y-58.3722.740-61.112
5Y1,052.3953.884+1,048.511
10Y564.8764.281+560.595
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Accumulated Other Comprehensive Income  -1,775-674-2,449970-1,479-534-2,0142,863849
Gross Profit  761-467294424718-170548-2,766-2,218



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. All numbers in thousands.

Summary
Total Assets9,944
Total Liabilities54,323
Total Stockholder Equity-44,379
 As reported
Total Liabilities 54,323
Total Stockholder Equity+ -44,379
Total Assets = 9,944

Assets

Total Assets9,944
Total Current Assets6,417
Long-term Assets3,527
Total Current Assets
Cash And Cash Equivalents 3,807
Inventory 2,046
Other Current Assets 564
Total Current Assets  (as reported)6,417
Total Current Assets  (calculated)6,417
+/-0
Long-term Assets
Property Plant Equipment 1,774
Long-term Assets Other 1,649
Long-term Assets  (as reported)3,527
Long-term Assets  (calculated)3,423
+/- 104

Liabilities & Shareholders' Equity

Total Current Liabilities53,211
Long-term Liabilities1,112
Total Stockholder Equity-44,379
Total Current Liabilities
Short-term Debt 39,753
Accounts payable 1,889
Other Current Liabilities 11,569
Total Current Liabilities  (as reported)53,211
Total Current Liabilities  (calculated)53,211
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,112
Long-term Liabilities  (calculated)0
+/- 1,112
Total Stockholder Equity
Common Stock4,604
Retained Earnings -250,676
Accumulated Other Comprehensive Income 849
Other Stockholders Equity 200,844
Total Stockholder Equity (as reported)-44,379
Total Stockholder Equity (calculated)-44,379
+/-0
Other
Cash and Short Term Investments 3,807
Common Stock Shares Outstanding 36,602
Liabilities and Stockholders Equity 9,944
Net Debt 36,304
Short Long Term Debt Total 40,111



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
6,042
4,682
3,808
3,519
3,341
9,350
14,213
14,705
26,025
10,101
9,944
9,94410,10126,02514,70514,2139,3503,3413,5193,8084,6826,042
   > Total Current Assets 
5,853
4,420
3,405
3,272
3,099
8,522
13,441
12,891
23,089
6,296
6,417
6,4176,29623,08912,89113,4418,5223,0993,2723,4054,4205,853
       Cash And Cash Equivalents 
4,091
1,427
797
1,684
1,318
5,586
11,016
9,600
18,875
2,584
3,807
3,8072,58418,8759,60011,0165,5861,3181,6847971,4274,091
       Net Receivables 
376
258
571
304
430
625
24
383
114
43
0
04311438324625430304571258376
       Inventory 
1,386
2,144
1,964
1,271
1,235
1,598
1,472
2,139
2,621
2,296
2,046
2,0462,2962,6212,1391,4721,5981,2351,2711,9642,1441,386
   > Long-term Assets 
190
262
403
248
242
829
772
1,815
2,936
3,805
3,527
3,5273,8052,9361,815772829242248403262190
       Property Plant Equipment 
107
160
299
206
184
765
705
1,268
2,068
2,316
1,774
1,7742,3162,0681,268705765184206299160107
       Intangible Assets 
0
136
268
186
138
159
0
0
0
0
0
000001591381862681360
       Long-term Assets Other 
82
-35
104
42
58
-96
67
464
782
1,388
1,649
1,6491,38878246467-965842104-3582
> Total Liabilities 
3,193
4,966
10,475
8,130
22,101
8,424
14,101
15,492
28,178
29,566
54,323
54,32329,56628,17815,49214,1018,42422,1018,13010,4754,9663,193
   > Total Current Liabilities 
2,455
4,120
4,843
5,554
18,727
5,315
5,966
7,180
15,148
19,466
53,211
53,21119,46615,1487,1805,9665,31518,7275,5544,8434,1202,455
       Short-term Debt 
0
0
0
2,820
12,073
659
264
-2,239
4,790
8,087
39,753
39,7538,0874,790-2,23926465912,0732,820000
       Short Long Term Debt 
0
0
0
2,820
12,073
459
0
0
4,483
7,818
0
07,8184,4830045912,0732,820000
       Accounts payable 
1,268
1,304
1,803
909
1,908
1,687
2,013
2,193
3,227
2,737
1,889
1,8892,7373,2272,1932,0131,6871,9089091,8031,3041,268
       Other Current Liabilities 
1,187
2,816
3,039
1,825
4,746
0
3,689
4,530
6,966
8,642
11,569
11,5698,6426,9664,5303,68904,7461,8253,0392,8161,187
   > Long-term Liabilities 
738
846
5,632
2,576
3,374
3,110
8,135
8,312
13,030
10,101
1,112
1,11210,10113,0308,3128,1353,1103,3742,5765,632846738
       Long term Debt Total 
0
0
4,664
1,757
2,582
2,566
0
0
0
0
0
000002,5662,5821,7574,66400
       Other Liabilities 
0
846
968
819
792
544
539
510
228
0
0
002285105395447928199688460
> Total Stockholder Equity
2,849
-285
-6,668
-4,611
-18,760
926
113
-787
-2,153
-19,465
-44,379
-44,379-19,465-2,153-787113926-18,760-4,611-6,668-2852,849
   Common Stock
3,806
4,411
860
955
888
1,307
1,635
1,925
2,460
2,926
4,604
4,6042,9262,4601,9251,6351,3078889558604,4113,806
   Retained Earnings -250,676-206,022-173,458-142,695-119,080-99,974-85,003-71,082-62,857-53,501-41,944
   Capital Surplus 
0
48,623
55,438
65,157
64,963
100,661
0
0
0
0
0
00000100,66164,96365,15755,43848,6230
   Treasury Stock0000000-193000
   Other Stockholders Equity 
40,987
48,806
55,458
65,708
65,577
100,661
119,333
142,433
170,324
185,644
200,844
200,844185,644170,324142,433119,333100,66165,57765,70855,45848,80640,987



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue106
Cost of Revenue-2,324
Gross Profit-2,218-2,218
 
Operating Income (+$)
Gross Profit-2,218
Operating Expense-16,488
Operating Income-18,706-18,706
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense16,4880
 
Net Interest Income (+$)
Interest Income-
Interest Expense-26,363
Other Finance Cost-26,363
Net Interest Income-
 
Pretax Income (+$)
Operating Income-18,706
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-44,3736,961
EBIT - interestExpense = -44,372
-44,374
-18,291
Interest Expense26,363
Earnings Before Interest and Taxes (EBIT)-18,009-18,010
Earnings Before Interest and Taxes (EBITDA)-17,394
 
After tax Income (+$)
Income Before Tax-44,373
Tax Provision--
Net Income From Continuing Ops--44,373
Net Income-44,654
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses18,812
Total Other Income/Expenses Net-25,6670
 

Technical Analysis of Sequana Medical NV
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sequana Medical NV. The general trend of Sequana Medical NV is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sequana Medical NV's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Sequana Medical NV Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sequana Medical NV.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.63 < 1.72 < 1.774.

The bearish price targets are: 1.104 > 1.05 > 0.9.

Know someone who trades $SEQUA? Share this with them.👇

Sequana Medical NV Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sequana Medical NV. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sequana Medical NV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sequana Medical NV. The current macd is 0.10771717.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sequana Medical NV price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sequana Medical NV. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sequana Medical NV price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sequana Medical NV Daily Moving Average Convergence/Divergence (MACD) ChartSequana Medical NV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sequana Medical NV. The current adx is 44.09.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sequana Medical NV shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Sequana Medical NV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sequana Medical NV. The current sar is 1.18196374.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sequana Medical NV Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sequana Medical NV. The current rsi is 72.84. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Sequana Medical NV Daily Relative Strength Index (RSI) ChartSequana Medical NV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sequana Medical NV. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sequana Medical NV price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Sequana Medical NV Daily Stochastic Oscillator ChartSequana Medical NV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sequana Medical NV. The current cci is 190.76.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sequana Medical NV Daily Commodity Channel Index (CCI) ChartSequana Medical NV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sequana Medical NV. The current cmo is 54.68.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sequana Medical NV Daily Chande Momentum Oscillator (CMO) ChartSequana Medical NV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sequana Medical NV. The current willr is -10.37277147.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sequana Medical NV Daily Williams %R ChartSequana Medical NV Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sequana Medical NV.

Sequana Medical NV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sequana Medical NV. The current atr is 0.10654555.

Sequana Medical NV Daily Average True Range (ATR) ChartSequana Medical NV Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sequana Medical NV. The current obv is 481,413.

Sequana Medical NV Daily On-Balance Volume (OBV) ChartSequana Medical NV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sequana Medical NV. The current mfi is 84.38.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Sequana Medical NV Daily Money Flow Index (MFI) ChartSequana Medical NV Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sequana Medical NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Sequana Medical NV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sequana Medical NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.835
Ma 20Greater thanMa 501.116
Ma 50Greater thanMa 1001.063
Ma 100Greater thanMa 2001.198
OpenGreater thanClose1.598
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sequana Medical NV with someone you think should read this too:
  • Are you bullish or bearish on Sequana Medical NV? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sequana Medical NV? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sequana Medical NV

I send you an email if I find something interesting about Sequana Medical NV.


Comments

How you think about this?

Leave a comment

Stay informed about Sequana Medical NV.

Receive notifications about Sequana Medical NV in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.